acquiring would this work for the for migraines headache . PSDV eye delivery system delivers up to 3yrs for DME.
Sentiment: Strong Buy
Just read that Allergan acquired a private company- Innocore for drug delivery and a couple of additional clinical and preclinical development drugs. They have a delivery technology called SynBiosys.
Company looks interesting but not what AGN would be interested in. PSDV has nearly $270 million in negative retained earnings, continues to lose more and is simply not investment quality.